Clinical trial · Interventional
Timing of Menstrual Cycle and Surgery in Treating Premenopausal Women With Stage I, Stage II, or Stage III Breast Cancer
Timing of Breast Cancer Surgery, Menstrual Cycle and Prognosis
NCT00005079CI-TRIAL-00010327completedPhase 3ClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
RATIONALE: The timing of breast cancer surgery within the menstrual cycle may affect outcome. It is not yet known if treatment is more effective during the initial or final phase of the menstrual cycle. PURPOSE: Phase III trial to determine the effect of menstrual cycle phase at surgery in treating premenopausal women who have stage I, stage II, or stage III breast cancer.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| conventional surgery | Procedure | — | UNRESOLVED |
Eligibility
Eligibility (as posted)
- Sex
- Female
Show eligibility criteria text
DISEASE CHARACTERISTICS: * Histologically confirmed stage I, II, or III primary breast cancer undergoing breast surgery * Invasive disease (e.g., lobular or ductal) * No bilateral disease * No distant metastases * Premenopausal * Regular menses (no amenorrhea of more than 90 days) without hormone replacement * Documented last menstrual period * Hormone receptor status: * Not specified PATIENT CHARACTERISTICS: Age: * Premenopausal Sex: * Female Menopausal status: * See Disease Characteristics Performance status: * Not specified Life expectancy: * Not specified Hematopoietic: * Not specified Hepatic: * Not specified Renal: * Not specified Other: * No other prior malignancies * Not pregnant or nursing PRIOR CONCURRENT THERAPY: Biologic therapy: * Not specified Chemotherapy: * No preoperative chemotherapy Endocrine therapy: * No concurrent hormonal replacement therapy * No concurrent interruptive oral contraceptive use of less than 3 months Radiotherapy: * Not specified Surgery: * See Disease Characteristics * No prior hysterectomy and/or bilateral oophorectomy
References
Publications (0)
Data not yet available
No reference posted for this study.